A CLINICAL STUDY ON JATAMAYADI UPANAHA SWEDA IN JANU SANDHIGATAVATA (OSTEOARTHRITIS OF KNEE JOINT)
DOI:
https://doi.org/10.70066/jahm.v3i6.275Keywords:
Sandhigatavata, jatamayadi upanaha, Snehana, Swedana, osteoarthritis.Abstract
Introduction: Sandhigatavata is one among the vatavyadhi. It may be correlated to osteoarthritis due to
resemblance in signs and symptoms. Though, many treatments are available for osteoarthritis, pain
management is essentially preferred. Snehana and swedana are prescribed as common treatments in
vatavyadhi. Upanaha sweda is one among the modality of swedana used widely in the management of
sandhigatavata, which is found to be beneficial clinically too. So this clinical study is planned to evaluate the
efficacy of jatamayadi upanaha in the management of sandhigatavata (OA of knee) as, it has vatahara,
shothahara (antiinflammatory), shoolaghna (analgesic) action. Materials and methods: 20 patients fulfilling
the diagnostic and inclusion criteria belonging to either sex were selected for this single blind study. Upanaha
was prepared and applied over affected joints for 7 days. Result: Subjective and objective parameters were
suitably graded to assess the results based on clinical observations before and after treatment. Statistically
results were highly significant (P<0.001) in criteria like pain at rest, ability to climb up and walk down stairs,
ability to squat, swelling, tenderness and range of movement. In the present study, 20% of the subjects got
marked improvement, 40% got moderate, 35% mild and 5% got poor response. Conclusion: Jatamayadi
upanaha having kapha-vatashamaka and vedanasthapaka properties is very much beneficial to reduce
swelling and tenderness instantly.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Divya Dev

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.